Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients

Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients is organized by Clinical Care Options (CCO), LLC.,Released: January 12, 2023,Expiration: January 11, 2024,Goal:,The goal of this activity is to educate oncologists, oncology nurses, pharmacists, physician assistants/physician associates, and other HCPs about recent developments in the care of TNBC to optimally individualize therapy for this patient population.,Learning Objectives:,• Evaluate available data on the use of immune-based therapies as part of neoadjuvant/adjuvant treatment for early-stage triple-negative breast cancer,• Plan individualized first-line treatment for individual patients with locally advanced or metastatic triple-negative breast cancer,• Apply clinical evidence and expert recommendations using antibody–drug conjugates for patients with progressive triple-negative breast cancer after 1 or more previous lines of therapy,• Foster collaborative discussions between patients/caregivers and providers on guidelines and recent clinical evidence to guide personalized treatment planning for triple negative breast cancer,• Implement resources to engage patients in shared decision-making about treatment for triple negative breast cancer ,• Appraise ongoing clinical trials assessing new targeted agents and novel approaches for appropriate patients with triple-negative breast cancer,Additional details will be posted as soon as information is available.